A Central Role for Induced Regulatory T Cells in Tolerance Induction in Experimental Colitis

Dipica Haribhai(Rheumatology Consultants), Wen Lin(University of California, Los Angeles), Brandon Edwards(Rheumatology Consultants), Jennifer Ziegelbauer(Rheumatology Consultants), Nita H. Salzman(Pediatrics and Genetics), Marc Carlson(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Shun-Hwa Li(Medical College of Wisconsin), Pippa Simpson(Medical College of Wisconsin), Talal A. Chatila(University of California, Los Angeles), Calvin B. Williams(Rheumatology Consultants)
The Journal of Immunology
March 1, 2009
Cited by 219Open Access
Full Text

Abstract

In addition to thymus-derived or natural T regulatory (nT(reg)) cells, a second subset of induced T regulatory (iT(reg)) cells arises de novo from conventional CD4(+) T cells in the periphery. The function of iT(reg) cells in tolerance was examined in a CD45RB(high)CD4(+) T cell transfer model of colitis. In situ-generated iT(reg) cells were similar to nT(reg) cells in their capacity to suppress T cell proliferation in vitro and their absence in vivo accelerated bowel disease. Treatment with nT(reg) cells resolved the colitis, but only when iT(reg) cells were also present. Although iT(reg) cells required Foxp3 for suppressive activity and phenotypic stability, their gene expression profile was distinct from the established nT(reg) "genetic signature," indicative of developmental and possibly mechanistic differences. These results identified a functional role for iT(reg) cells in vivo and demonstrated that both iT(reg) and nT(reg) cells can act in concert to maintain tolerance.


Related Papers

No related papers found

Powered by citation graph analysis